SLNOW
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
SLNOW
Delisted
SLNOW was delisted on the 8th of November, 2019.
3 hedge funds and large institutions have $29K invested in Soleno Therapeutics, Inc. Series A Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
VC
1
Vivo Capital
Palo Alto,
California
|
$27K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$2K |
| 3 |
3
Hudson Bay Capital Management
Stamford,
Connecticut
|
$0 |
| 4 |
VF
4
Virtu Financial
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VC
1
Vivo Capital
Palo Alto,
California
| $27K | 188,772 | -755,086 | -80% |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | 10,418 | -41,673 | -80% |
|
|
3
Hudson Bay Capital Management
Stamford,
Connecticut
| – | – | -30,000 | Closed |
|
|
VF
4
Virtu Financial
New York
| – | – | -12,516 | Closed |
|
|
BG
5
Bollard Group
Boston,
Massachusetts
| $0 | 2,197 | -8,788 | -80% |
|